Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.
about
Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and BeyondThe calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritisBudesonide and formoterol reduce early innate anti-viral immune responses in vitro.The airway epithelium: soldier in the fight against respiratory virusesRSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity.Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model.Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma.Effects of β(2) Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway FibroblastsBronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma.A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokinesHuman rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice.The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPDCistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory EffectsTulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responsesGlucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon.Salmeterol/fluticasone propionate combination in the treatment of COPD.Epithelial cells and airway diseases.Corticosteroids in respiratory diseases in children.Updates in the relationship between human rhinovirus and asthma.Virus infection-induced bronchial asthma exacerbation.Acute asthma exacerbations in childhood: risk factors, prevention and treatment.Viral respiratory tract infections and asthma in early life: cause and effect?Advances in the treatment of virus-induced asthma.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.Basic research on virus-induced asthma exacerbation: inhibition of inflammatory chemokine expression by fluticasone propionateCorticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium.Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors.Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon.CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection.Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A.
P2860
Q26786359-37EC44C4-5DE5-461A-A830-B611A83C1D66Q28485981-F3A991CA-8C8B-4B2A-96C3-F9061053A7AEQ34085817-12A3762A-F764-4835-8D0D-5494D5B72176Q34491598-E4E6E50A-3D3C-4AC3-AA21-37CDEAE8842DQ34910463-7F5E1C97-28E0-41E6-A527-11DCCDAE3BDBQ35140534-4BC0BD4B-FB06-4BDF-9B55-C0635168706FQ35173486-FF5AFFE9-3966-4AAD-A945-B4736F38D4BBQ35450286-4A0E9212-C3A3-446E-8995-04F58E608DE6Q36225732-BE4038D8-597F-4F2E-B7CC-9B7755232381Q36510045-617EAF54-6F5C-47DD-B669-19BC122BAA46Q36648886-FB4558C6-30E7-456C-A59F-EE691E04A6FAQ36657676-2ADB5393-1B27-43EA-9374-73E4D5CA9A7EQ37017315-D73F92BF-9743-4E01-B951-D761DC050987Q37066464-A2AF2DDA-3D1C-49BD-8ADF-2E8030A6CCD5Q37328046-136FD866-71C9-43AD-B8AA-F0CA4D28D591Q37365528-05D440B7-0F29-4CE9-8ADE-A02506CBE7ABQ37741110-BF6C0B89-1330-431B-AB1C-84B359C4720FQ37754942-C72D045C-CA01-44D6-8892-1A2944AC1190Q37891137-6C6AE2DD-79CD-40D4-8DD2-69034472067BQ37932864-431CDFC2-ADC4-4E1A-9A31-28BCFB941463Q38006712-3922B350-0C0F-4EFE-994A-6A9541366EADQ38042428-AA63555C-936F-4706-8833-F86D9C46528BQ38066980-1A739BA5-0B72-4452-8A6F-AEDBA30C1955Q38172663-6BEF9E47-2D74-435B-A088-AD9558429DB9Q38810784-9126F166-CDB5-4186-80B6-91C2CE079A36Q38959067-0391A19D-0C65-4194-A1C8-059A8D6F0E1DQ39144680-AFE8AC2B-8F33-453E-9D74-F7B0A9E61B94Q39285649-E02E263C-A500-44A9-8CAA-845A0CD5051AQ39423972-607DD271-AD47-4333-8443-868D2303D002Q40225104-55A1530F-9625-4FF2-AA73-AD28AEF9317DQ40257015-9C9DBCC4-55F6-4630-9E30-6CBAD0867DC0Q41845119-D04AC991-6853-454F-9DF2-FF37BBF34D9CQ46057464-4A26F452-8D4B-4B59-8B9D-A89C90037516Q46513005-0179E694-98CB-4707-955B-DDB9E2D01FC7
P2860
Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Combination therapy: Synergist ...... es in airway epithelial cells.
@en
Combination therapy: Synergist ...... es in airway epithelial cells.
@nl
type
label
Combination therapy: Synergist ...... es in airway epithelial cells.
@en
Combination therapy: Synergist ...... es in airway epithelial cells.
@nl
prefLabel
Combination therapy: Synergist ...... es in airway epithelial cells.
@en
Combination therapy: Synergist ...... es in airway epithelial cells.
@nl
P2860
P356
P1476
Combination therapy: Synergist ...... nes in airway epithelial cells
@en
P2093
Malcolm W Johnson
P2860
P304
P356
10.1165/RCMB.2005-0385OC
P577
2006-01-19T00:00:00Z